In stock
Bortada 2.5 mg Solution for injection 1.4ml Vial
In stock
Only 1 left
SKU
10331014276
Bortada 2.5 mg Solution for injection contains Bortezomib, an antineoplastic agent. It is primarily used for the treatment of multiple myeloma and mantle cell lymphoma by inhibiting proteasomes in cancer cells. This prescription medication is administered by healthcare professionals for targeted cancer therapy.
Based on information typically found on leading e-commerce and pharmaceutical platforms like Nahdi Online, , and , here is a detailed overview of Bortada 2.5 mg Solution for injection 1.4ml Vial:
Bortada 2.5 mg Solution for injection 1.4ml Vial contains Bortezomib, a potent antineoplastic agent used in the treatment of certain cancers.
As a proteasome inhibitor, Bortada works by blocking the action of proteasomes within cells, leading to the disruption of protein regulation and ultimately inducing programmed cell death (apoptosis) in cancer cells.
This targeted approach makes Bortada an essential medication in specific oncology protocols.
Bortada 2.5 mg Solution for injection is administered by a healthcare professional.
The specific dosage and administration schedule will be determined by your doctor based on your medical condition, body surface area, and response to treatment.
Bortada 2.5 mg Solution for injection 1.4ml Vial: Targeted Therapy for Specific Cancers
Bortada 2.5 mg Solution for injection 1.4ml Vial contains Bortezomib, a potent antineoplastic agent used in the treatment of certain cancers.
As a proteasome inhibitor, Bortada works by blocking the action of proteasomes within cells, leading to the disruption of protein regulation and ultimately inducing programmed cell death (apoptosis) in cancer cells.
This targeted approach makes Bortada an essential medication in specific oncology protocols.
Benefits of Use:
- Effective in treating multiple myeloma, a cancer of plasma cells.
- Also indicated for the treatment of mantle cell lymphoma, a type of non-Hodgkin lymphoma.
- Acts through a specific mechanism of action by inhibiting proteasomes, which are crucial for cellular protein degradation, leading to anti-tumor effects.
- Can be used alone or in combination with other therapeutic agents as part of a comprehensive treatment regimen.
How to Use:
Bortada 2.5 mg Solution for injection is administered by a healthcare professional.
The specific dosage and administration schedule will be determined by your doctor based on your medical condition, body surface area, and response to treatment.
- Bortada is administered either intravenously (IV) or subcutaneously (SC).
- Your healthcare provider will prepare the solution for injection immediately prior to use.
- It is crucial to adhere strictly to the dosing schedule prescribed by your physician.
- Do not attempt to self-administer this medication.
- Regular monitoring by your medical team is essential throughout the treatment course.
Caution & Warnings:
- Bortada should only be administered under the supervision of a physician experienced in the use of antineoplastic therapy.
- This medication can cause serious side effects, including peripheral neuropathy, thrombocytopenia, neutropenia, and gastrointestinal disturbances.
- Patients should be monitored for signs of peripheral neuropathy (numbness, tingling, pain) and dose adjustments may be necessary.
- Complete blood counts should be performed regularly during treatment to monitor for myelosuppression.
- Liver function tests should be monitored, as liver damage can occur.
- Not recommended for use during pregnancy or breastfeeding due to potential harm to the fetus or infant. Effective contraception is advised for patients of reproductive potential.
- Avoid activities requiring mental alertness, such as driving or operating machinery, if you experience dizziness or fatigue.
- Inform your doctor about all other medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins, to avoid potential drug interactions.
- Store the vial in a refrigerator (2°C - 8°C) and protect from light. Do not freeze.
Ingredients:
- Active Ingredient: Bortezomib 2.5 mg
- Inactive Ingredients: (Specific inactive ingredients not provided, but typically include excipients necessary for solubility and stability in an injectable solution).
Product Details:
- Product Name: Bortada 2.5 mg Solution for injection
- Strength: 2.5 mg
- Volume: 1.4 ml per vial
- Form: Solution for injection
- Package Type: Vial
| Gtin | 707210852 |
|---|---|
| Recommended Sale Price | 2164.65 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | BORTEZOMIB |
| SFDA Reg. No | 707210852 |
| IBC | 707210852 |
| Drug Type | Prescription |
| Scientific Name | Bortezomib |
| Strength | 2.5 |
| Strength Unit | mg |
| Form | Solution for injection |
| Admin Route | Intravenous (IV), Subcutaneous (SC) |
| Size | 1.4 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 Vial |
| Storage conditions | Store the vial in a refrigerator (2°C - 8°C) and protect from light. Do not freeze. |
| Refrigerator Storage | Yes |
Products you might like
